eShowcase
IntraLinks' IntraLinks, Pharsight Corp.'s Trial Simulator, and Thomson CenterWatch's Drugs in Clinical Trials Database and eDirectory of the Clinical Trials Industry
Informed Consent: Reading and Understanding Are Not the Same
IRBs often set an arbitrary grade-level requirement?such as sixth or eighth grade?at which consent forms are supposed to be written...
Reconsidering Third-Party Companies for Subject Enrollment
Central call centers can relieve sites of tedious scheduling and record keeping, freeing them to focus on physical exams and other core tasks.
Gathering ?Buts? in May
The passing of the EU Directive deadline next month is unlikely to quell the stormy debate over its far-reaching impact.
New Leadership, New Policies at FDA
McClellan shifts to head Medicare after delivering new proposals to block counterfeits, add bar codes, and assess drug imports.
Parallel Universes?Technology in Health Care and Clinical Development
Although the worlds of EMR and clinical trial technologies are similar, they have quite a few differences as well.
Subject Recruitment and Retention: Barriers to Success
Study findings identify various factors affecting subject enrollment in today?s clinical trial world.
